dc.creator | Busquets O. | |
dc.creator | Ettcheto M. | |
dc.creator | Cano A. | |
dc.creator | Manzine P.R. | |
dc.creator | Sánchez-Lopez E. | |
dc.creator | Espinosa-Jiménez T. | |
dc.creator | Verdaguer E. | |
dc.creator | Castro-Torres R.D. | |
dc.creator | Beas-Zarate C. | |
dc.creator | Sureda F.X. | |
dc.creator | Olloquequi J. | |
dc.creator | Auladell C. | |
dc.creator | Folch J. | |
dc.creator | Camins A. | |
dc.date.accessioned | 2020-09-02T22:13:36Z | |
dc.date.accessioned | 2022-11-08T20:24:23Z | |
dc.date.available | 2020-09-02T22:13:36Z | |
dc.date.available | 2022-11-08T20:24:23Z | |
dc.date.created | 2020-09-02T22:13:36Z | |
dc.date.issued | 2020 | |
dc.identifier | 21, 1, - | |
dc.identifier | 16616596 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3808 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145246 | |
dc.language | en | |
dc.publisher | MDPI AG | |
dc.subject | Brain | |
dc.subject | C-Jun-N-terminal kinase | |
dc.subject | Cognitive impairment | |
dc.subject | Epilepsy | |
dc.subject | JNK inhibitor | |
dc.subject | Metabolism | |
dc.subject | Type 2 diabetes | |
dc.subject | activating transcription factor 6 | |
dc.subject | BIM protein | |
dc.subject | cytochrome c | |
dc.subject | cytochrome P450 | |
dc.subject | glucose regulated protein 78 | |
dc.subject | glutathione peroxidase | |
dc.subject | growth arrest and DNA damage inducible protein 153 | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | insulin | |
dc.subject | interleukin 1beta | |
dc.subject | isoenzyme | |
dc.subject | licochalcone A | |
dc.subject | mitogen activated protein kinase | |
dc.subject | mitogen activated protein kinase 1 | |
dc.subject | mitogen activated protein kinase 3 | |
dc.subject | mitogen activated protein kinase 7 | |
dc.subject | mitogen activated protein kinase p38 | |
dc.subject | peroxiredoxin | |
dc.subject | protein Bax | |
dc.subject | protein bcl 2 | |
dc.subject | protein bcl xl | |
dc.subject | protein c jun | |
dc.subject | protein tyrosine phosphatase 1B | |
dc.subject | proton transporting adenosine triphosphate synthase | |
dc.subject | reactive oxygen metabolite | |
dc.subject | second mitochondrial activator of caspase | |
dc.subject | stress activated protein kinase | |
dc.subject | stress activated protein kinase inhibitor | |
dc.subject | tumor necrosis factor receptor associated factor 2 | |
dc.subject | unindexed drug | |
dc.subject | antidiabetic agent | |
dc.subject | isoprotein | |
dc.subject | mitogen activated protein kinase | |
dc.subject | neuroprotective agent | |
dc.subject | stress activated protein kinase | |
dc.subject | apoptosis | |
dc.subject | autophagy (cellular) | |
dc.subject | cell cycle progression | |
dc.subject | cell death | |
dc.subject | cell proliferation | |
dc.subject | cell respiration | |
dc.subject | citric acid cycle | |
dc.subject | cognitive defect | |
dc.subject | dementia | |
dc.subject | dentate gyrus | |
dc.subject | disease course | |
dc.subject | dyslipidemia | |
dc.subject | endoplasmic reticulum stress | |
dc.subject | epilepsy | |
dc.subject | epileptogenesis | |
dc.subject | human | |
dc.subject | hyperinsulinemia | |
dc.subject | in situ hybridization | |
dc.subject | insulin resistance | |
dc.subject | metabolic syndrome X | |
dc.subject | nerve degeneration | |
dc.subject | neuroprotection | |
dc.subject | non insulin dependent diabetes mellitus | |
dc.subject | nonhuman | |
dc.subject | obesity | |
dc.subject | oxidative phosphorylation | |
dc.subject | oxidative stress | |
dc.subject | protein degradation | |
dc.subject | protein phosphorylation | |
dc.subject | Review | |
dc.subject | seizure | |
dc.subject | temporal lobe epilepsy | |
dc.subject | unfolded protein response | |
dc.subject | upregulation | |
dc.subject | animal | |
dc.subject | brain | |
dc.subject | cognitive defect | |
dc.subject | drug effect | |
dc.subject | epilepsy | |
dc.subject | MAPK signaling | |
dc.subject | metabolism | |
dc.subject | mitochondrion | |
dc.subject | pathology | |
dc.subject | physiology | |
dc.subject | Animals | |
dc.subject | Brain | |
dc.subject | Cognitive Dysfunction | |
dc.subject | Diabetes Mellitus, Type 2 | |
dc.subject | Endoplasmic Reticulum Stress | |
dc.subject | Epilepsy | |
dc.subject | Humans | |
dc.subject | Hypoglycemic Agents | |
dc.subject | JNK Mitogen-Activated Protein Kinases | |
dc.subject | MAP Kinase Signaling System | |
dc.subject | Mitochondria | |
dc.subject | Mitogen-Activated Protein Kinases | |
dc.subject | Neuroprotective Agents | |
dc.subject | Protein Isoforms | |
dc.title | Role of c-jun N-terminal kinases (JNKs) in epilepsy and metabolic cognitive impairment | |
dc.type | Review | |